NIH, under fire, freezes grant for conference on genetics and crime
Article Abstract:
The National Institutes of Health (NIH) delayed financing of a conference on the connection between genetics and crime after minority groups denounced the meeting as an indirect insult to African-Americans who comprise 46% of the prison population. The University of Maryland's Institute for Philosophy and Public Policy wants to sponsor the conference, called 'Genetic Factors in Crime: Findings, Uses and Implications' with the aid of a $100,000 NIH grant. NIH director Bernadine Healy instructed conference organizer David Wasserman to expand the conference's scope.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
NSF will experiment with fixed budgets in an effort to simplify grants process
Article Abstract:
The National Science Foundation (NSF) on Oct 1, 1992 will begin trying out a new process for distributing research grants to mathematicians. Under the new process, applicants will not have to include a proposed budget when asking for funds and will be awarded grants at fixed, predetermined amounts. NSF wants to find out if these experimental procedures will rectify the complexities that have vexed the grant approval process in the past. NSF will continue with this test at least for the duration of FY 1993.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
- Abstracts: A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles
- Abstracts: If biological diversity has a price, who sets it and who should benefit? Centocor staggered by poor clinical results